Raffa P.C. Revenue and Competitors

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Raffa P.C.'s estimated annual revenue is currently $26.9M per year.(i)
  • Raffa P.C.'s estimated revenue per employee is $312,558

Employee Data

  • Raffa P.C. has 86 Employees.(i)
  • Raffa P.C. grew their employee count by -20% last year.

Raffa P.C.'s People

NameTitleEmail/Phone
1
Assurance DirectorReveal Email/Phone
2
Manager, Managed Accounting ServicesReveal Email/Phone
3
Audit ManagerReveal Email/Phone
4
Manager, Document ProductionReveal Email/Phone
5
PartnerReveal Email/Phone
6
Senior IIReveal Email/Phone
7
Office CoordinatorReveal Email/Phone
8
Staff AccountantReveal Email/Phone
9
PrincipalReveal Email/Phone
10
Staff I AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M12-8%N/AN/A
#2
$34.2M1349%N/AN/A
#3
$10M53-2%N/AN/A
#4
$57.8M2195%N/AN/A
#5
$13.4M602%N/AN/A
#6
$8.2M4817%N/AN/A
#7
N/A119747%$97.1MN/A
#8
$4.3M2916%N/AN/A
#9
$14M740%N/AN/A
#10
$12.3M576%N/AN/A
Add Company

What Is Raffa P.C.?

TransitionGuides is a unique consulting and educational services company that enables nonprofit organizations to capitalize on opportunities that come with transitions. Headquartered in suburban Washington, DC, our team of nationally recognized consultants specializes in leadership transitions, succession planning, strategy development, and managing organizational change. We have successfully led hundreds of organizations through leadership and other pivotal changes. Clients include local and national nonprofits, foundations, associations, and select government agencies. TransitionGuides is a pioneer in leading organizations to identify and harness the power of change.

keywords:N/A

N/A

Total Funding

86

Number of Employees

$26.9M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Raffa P.C. News

2022-03-30 - Multimodal Analgesic Regimen for Acute Sickle Cell Pain | JPR

Hillery CA, Kerstein PC, Vilceanu D, et al. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.5M86N/AN/A
#2
$22.1M86-23%N/A
#3
$15M866%N/A
#4
$27.2M861%N/A
#5
$20.2M86-9%N/A